The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Size Is Forecasted For The Andexxa (Ondexxya) Market By 2030 Based On Its 2026 Value?
Historical growth was primarily driven by the widespread adoption of factor Xa inhibitors, occurrences of emergency bleeding, the regulatory approval of reversal agents, the demand for hospital critical care, and an aging population.
The expected expansion during the forecast period is driven by the increasing prevalence of cardiovascular diseases, a rise in anticoagulant prescriptions, the broadening of trauma care services, the enhancement of emergency protocols, and a growing volume of surgical interventions. Key developments anticipated for this period include a heightened need for anticoagulant reversal, advancements in emergency bleeding management, the prevalence of hospital-based critical care therapies, a greater adoption of factor Xa inhibitors, and a strong emphasis on rapid hemostasis solutions.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19972&type=smp
What Core Drivers Are Transforming The Andexxa (Ondexxya) Market?
The anticipated rise in bleeding disorders is projected to stimulate the growth of the Andexxa (Ondexxya) market in the future. Bleeding disorders encompass a range of medical conditions that hinder the blood’s capacity to clot effectively, leading to excessive or prolonged bleeding episodes. The increase in these disorders can be attributed to factors such as improved diagnostic methods, greater public awareness, genetic predispositions, and the aging population, which collectively contribute to their increased recognition and detection. Andexxa (Ondexxya) is essential for managing bleeding disorders because it rapidly reverses the anticoagulant effects of factor Xa inhibitors, thereby preventing life-threatening bleeding in emergency scenarios. For instance, according to the National Blood Authority, an Australia-based blood management agency, there were 2,797 patients living with von Willebrand disease (VWD) in 2023–2024, up from 2,669 patients in 2022–2023, as reported in July 2025. Consequently, the increasing prevalence of bleeding disorders is a key driver for the Andexxa (Ondexxya) market’s expansion. The growing geriatric population is expected to propel the growth of the Andexxa (Ondexxya) market moving forward. The geriatric population consists of individuals aged 65 and above, who frequently face age-related health issues such as chronic illnesses, cognitive decline, and mobility challenges. This demographic is expanding globally due to increased life expectancy and advancements in healthcare. Andexxa (Ondexxya) is beneficial for the geriatric population because it helps reverse bleeding caused by blood thinners, which older adults are more likely to use due to conditions like atrial fibrillation. As an illustration, a report published by the World Health Organization (WHO), a Switzerland-based agency focused on international public health, stated in October 2022 that by 2030, one in six people worldwide is anticipated to be 60 years or older. Furthermore, by 2050, the global population of individuals aged 60 years or older is projected to reach 2.1 billion. Therefore, the increasing geriatric population is a significant factor driving the growth of the Andexxa (Ondexxya) market.
How Are Different Segment Groups Identified Within The Andexxa (Ondexxya) Market?
The andexxa (ondexxya) market covered in this report is segmented –
1) By Indication: Reversal Of Bleeding Caused By Factor Xa Inhibitors, Acute Major Bleeding Events, Emergency Surgery Or Procedures
2) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies
3) By End User: Adult, Geriatric, Pediatric
Which Trends Are Influencing The Expansion Of The Andexxa (Ondexxya) Market?
Major companies operating in the Andexxa market are concentrating on developing advanced anticoagulant reversal therapies to enhance patient safety during critical bleeding events. This targeted treatment neutralizes the effects of anticoagulant drugs, rapidly restoring normal clotting function and mitigating the risk of fatal bleeding. For instance, in January 2024, AstraZeneca India secured CDSCO approval to import and market andexanet alfa for life-threatening or refractory bleeding caused by Factor Xa inhibitors such as apixaban and rivaroxaban. This recently approved treatment involves an initial intravenous bolus given over 15–30 minutes, followed by a 2-hour infusion. Andexanet alfa has demonstrated efficacy and safety in clinical studies for major bleeding, allowing for the early restart of anticoagulation after an event, is well tolerated, and addresses a critical unmet need in patients utilizing novel oral anticoagulants.
Which Organizations Are Operating Within The Andexxa (Ondexxya) Market?
Major companies operating in the andexxa (ondexxya) market are AstraZeneca Plc
Access The Complete Andexxa (Ondexxya) Market Report:
https://www.thebusinessresearchcompany.com/report/andexxa-ondexxya-global-market-report
Which Region Leads The Andexxa (Ondexxya) Market By Size?
North America was the largest region in the andexxa (ondexxya) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the andexxa (ondexxya) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model